Search Results - "Ikeda, E"

Refine Results
  1. 1

    Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients by Nagata, Eiichiro, Ogino, Mieko, Iwamoto, Kounosuke, Kitagawa, Yasuhisa, Iwasaki, Yasuo, Yoshii, Fumihito, Ikeda, Joh-E

    Published in PloS one (24-02-2016)
    “…Bromocriptine mesylate (BRC), a dopamine D2 receptor agonist has been shown to confer neuroprotection, sustained motor function and slowed disease progression…”
    Get full text
    Journal Article
  2. 2

    A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection by Kanno, Takuya, Yasutake, Kaori, Tanaka, Kazunori, Hadano, Shinji, Ikeda, Joh-E

    Published in PloS one (09-10-2017)
    “…Therapeutic agents to the central nervous system (CNS) need to be efficiently delivered to the target site of action at appropriate therapeutic levels…”
    Get full text
    Journal Article
  3. 3

    Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms by Kano, Osamu, Tanaka, Kazunori, Kanno, Takuya, Iwasaki, Yasuo, Ikeda, Joh-E

    Published in Scientific reports (08-01-2018)
    “…The delineation of the molecular pathology underlying amyotrophic lateral sclerosis (ALS) is being hampered by the lack of suitable biomarkers. We have…”
    Get full text
    Journal Article
  4. 4

    Anterior insular volume decrease is associated with dysfunction of the reward system in patients with chronic pain by Ikeda, E., Li, T., Kobinata, H., Zhang, S., Kurata, J.

    Published in European journal of pain (01-07-2018)
    “…Background Chronification of pain is associated with both anatomical and functional alterations of the brain. Alteration in regional grey matter volume might…”
    Get full text
    Journal Article
  5. 5

    Functional Regulatory Mechanisms Underlying Bone Marrow Mesenchymal Stem Cell Senescence During Cell Passages by Iwata, T., Mizuno, N., Ishida, S., Kajiya, M., Nagahara, T., Kaneda-Ikeda, E., Yoshioka, M., Munenaga, S., Ouhara, K., Fujita, T., Kawaguchi, H., Kurihara, H.

    Published in Cell biochemistry and biophysics (01-06-2021)
    “…Mesenchymal stem cell (MSC) transplantation is an effective periodontal regenerative therapy. MSCs are multipotent, have self-renewal ability, and can…”
    Get full text
    Journal Article
  6. 6

    Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking by Hadano, Shinji, Otomo, Asako, Kunita, Ryota, Suzuki-Utsunomiya, Kyoko, Akatsuka, Akira, Koike, Masato, Aoki, Masashi, Uchiyama, Yasuo, Itoyama, Yasuto, Ikeda, Joh-E

    Published in PloS one (22-03-2010)
    “…ALS2/alsin is a guanine nucleotide exchange factor for the small GTPase Rab5 and involved in macropinocytosis-associated endosome fusion and trafficking, and…”
    Get full text
    Journal Article
  7. 7

    Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation by Shimozato, O, Waraya, M, Nakashima, K, Souda, H, Takiguchi, N, Yamamoto, H, Takenobu, H, Uehara, H, Ikeda, E, Matsushita, S, Kubo, N, Nakagawara, A, Ozaki, T, Kamijo, T

    Published in Oncogene (09-04-2015)
    “…Although CD133 has been considered to be a molecular marker for cancer stem cells, its functional roles in tumorigenesis remain unclear. We here examined the…”
    Get full text
    Journal Article
  8. 8

    Receptor-type protein tyrosine phosphatase [kappa] directly dephosphorylates CD133 and regulates downstream AKT activation by Shimozato, O, Waraya, M, Nakashima, K, Souda, H, Takiguchi, N, Yamamoto, H, Takenobu, H, Uehara, H, Ikeda, E, Matsushita, S, Kubo, N, Nakagawara, A, Ozaki, T, Kamijo, T

    Published in Oncogene (09-04-2015)
    “…Although CD133 has been considered to be a molecular marker for cancer stem cells, its functional roles in tumorigenesis remain unclear. We here examined the…”
    Get full text
    Journal Article
  9. 9

    A novel acylaminoimidazole derivative, WN1316, alleviates disease progression via suppression of glial inflammation in ALS mouse model by Tanaka, Kazunori, Kanno, Takuya, Yanagisawa, Yoshiko, Yasutake, Kaori, Inoue, Satoshi, Hirayama, Noriaki, Ikeda, Joh-E

    Published in PloS one (31-01-2014)
    “…Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron degenerative disease. Given that oxidative stress and resulting chronic neuronal…”
    Get full text
    Journal Article
  10. 10

    The Rab5 Activator ALS2/alsin Acts as a Novel Rac1 Effector through Rac1-activated Endocytosis by Kunita, Ryota, Otomo, Asako, Mizumura, Hikaru, Suzuki-Utsunomiya, Kyoko, Hadano, Shinji, Ikeda, Joh-E

    Published in The Journal of biological chemistry (01-06-2007)
    “…Mutations in the ALS2 gene cause a number of recessive motor neuron diseases, indicating that the ALS2 protein (ALS2/alsin) is vital for motor neurons. ALS2…”
    Get full text
    Journal Article
  11. 11

    Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis by Tanaka, Kazunori, Kanno, Takuya, Yanagisawa, Yoshiko, Yasutake, Kaori, Hadano, Shinji, Yoshii, Fumihito, Ikeda, Joh-E

    Published in Experimental neurology (01-11-2011)
    “…Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by a selective loss of upper and lower motor neurons. Since…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Prevalence of Cognitive Impairment in Heart Transplant Waiting-List Patients in a Developing Country by de Oliveira, F.M., Ikeda, E.T., Avila, M., Wozniak, I., Seguro, L., Santos, M., Feltrim, M., Barone, F., Issa, V., Lage, S., Bacal, F., Bocchi, E., Gaiotto, F., Nomura, C., Marcondes-Braga, F., Mangini, S.

    “…Cognitive impairment and mood deviation often occurs in patients with heart failure. Frailty and sarcopenia have been widely studied in patients with heart…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Cyclin-Dependent Kinases as a Therapeutic Target for Stroke by Osuga, H, Osuga, S, Wang, F, Fetni, R, Hogan, M J, Slack, R S, Hakim, A M, Ikeda, J E, Park, D S

    “…Cyclin-dependent kinases (CDKs) are commonly known to regulate cell proliferation. However, previous reports suggest that in cultured postmitotic neurons,…”
    Get full text
    Journal Article
  17. 17

    Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1 by Takada, Y, Gresh, L, Bozec, A, Ikeda, E, Kamiya, K, Watanabe, M, Kobayashi, K, Asano, K, Toyama, Y, Wagner, E F, Matsuo, K

    Published in Oncogene (08-09-2011)
    “…The role of the AP-1 transcription factor Fra-1 (encoded by Fosl1 ) in inflammatory responses associated with lung disease is largely unknown. Here, we show…”
    Get full text
    Journal Article
  18. 18
  19. 19

    ALS2/alsin deficiency in neurons leads to mild defects in macropinocytosis and axonal growth by Otomo, Asako, Kunita, Ryota, Suzuki-Utsunomiya, Kyoko, Mizumura, Hikaru, Onoe, Kyuichiro, Osuga, Hitoshi, Hadano, Shinji, Ikeda, Joh-E.

    “…Loss of function mutations in the ALS2 gene account for a number of juvenile/infantile recessive motor neuron diseases, indicating that its gene product,…”
    Get full text
    Journal Article
  20. 20

    Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration by Hadano, Shinji, Kunita, Ryota, Otomo, Asako, Suzuki-Utsunomiya, Kyoko, Ikeda, Joh-E

    Published in Neurochemistry international (01-07-2007)
    “…ALS2 is a causative gene for a juvenile autosomal recessive form of motor neuron diseases (MNDs), including amyotrophic lateral sclerosis 2 (ALS2), juvenile…”
    Get full text
    Journal Article